These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32682624)

  • 1. [Delays in the management of ocular complications of giant cell arteritis: A retrospective monocentric study of 33 patients].
    Sené T; Clavel G; Villeneuve D; Philibert M; Mauget-Faÿsse M; Lamirel C; Lecler A; Gout O; Hage R; Lidove O; Vignal-Clermont C
    Rev Med Interne; 2020 Oct; 41(10):661-666. PubMed ID: 32682624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of patients with giant cell arteritis who experience visual symptoms.
    Chean CS; Prior JA; Helliwell T; Belcher J; Mackie SL; Hider SL; Liddle J; Mallen CD
    Rheumatol Int; 2019 Oct; 39(10):1789-1796. PubMed ID: 31440812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and outcomes of patients with ophthalmologic involvement in giant-cell arteritis: A case-control study.
    Dumont A; Lecannuet A; Boutemy J; Maigné G; Martin-Silva N; Deshayes S; Audemard-Verger A; Sultan A; Planchard G; Aouba A; de Boysson H
    Semin Arthritis Rheum; 2020 Apr; 50(2):335-341. PubMed ID: 32192630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of visual manifestations and identification of risk factors for permanent vision loss in patients with giant cell arteritis.
    Baalbaki H; Jalaledin D; Lachance C; Febrer G; Rhéaume M; Makhzoum JP
    Clin Rheumatol; 2021 Aug; 40(8):3207-3217. PubMed ID: 33580374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ischemic optic neuropathies].
    Tournaire-Marques E
    J Fr Ophtalmol; 2020 Jun; 43(6):552-558. PubMed ID: 32451139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients.
    González-Gay MA; García-Porrúa C; Llorca J; Hajeer AH; Brañas F; Dababneh A; González-Louzao C; Rodriguez-Gil E; Rodríguez-Ledo P; Ollier WE
    Medicine (Baltimore); 2000 Sep; 79(5):283-92. PubMed ID: 11039076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Giant cell arteritis and vision complications. Illustrated by a 3-year study from hospitals in the county of Frederiksborg].
    Fledelius HC; Nissen KR
    Ugeskr Laeger; 1992 Mar; 154(10):631-4. PubMed ID: 1542969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature.
    Hayreh SS; Zimmerman B; Kardon RH
    Acta Ophthalmol Scand; 2002 Aug; 80(4):355-67. PubMed ID: 12190776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for severe cranial ischaemic complications in giant cell arteritis.
    Hočevar A; Ješe R; Tomšič M; Rotar Ž
    Rheumatology (Oxford); 2020 Oct; 59(10):2953-2959. PubMed ID: 32125431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort.
    Singh AG; Kermani TA; Crowson CS; Weyand CM; Matteson EL; Warrington KJ
    J Rheumatol; 2015 Feb; 42(2):309-15. PubMed ID: 25512481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: A Population-based Study.
    Saleh M; Turesson C; Englund M; Merkel PA; Mohammad AJ
    J Rheumatol; 2016 Aug; 43(8):1559-65. PubMed ID: 27252424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid management in giant cell arteritis.
    Chan CC; Paine M; O'Day J
    Br J Ophthalmol; 2001 Sep; 85(9):1061-4. PubMed ID: 11520757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant cell arteritis with ocular involvement successfully treated with tocilizumab and very short-course glucocorticoids: A case report.
    Khanna RK; Hage R; Lecler A; Sene T; Vignal-Clermont C; Clavel-Refregiers G
    J Fr Ophtalmol; 2021 Apr; 44(4):481-484. PubMed ID: 33712335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult giant cell arteritis: ocular manifestations.
    Hayreh SS; Podhajsky PA; Zimmerman B
    Am J Ophthalmol; 1998 Apr; 125(4):521-6. PubMed ID: 9559738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica.
    Narváez J; Estrada P; López-Vives L; Ricse M; Zacarías A; Heredia S; Gómez-Vaquero C; Nolla JM
    Semin Arthritis Rheum; 2015 Dec; 45(3):328-33. PubMed ID: 26186807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?
    Diamantopoulos AP; Haugeberg G; Lindland A; Myklebust G
    Rheumatology (Oxford); 2016 Jan; 55(1):66-70. PubMed ID: 26286743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic delay in patients with giant cell arteritis: results of a fast-track clinic.
    van Nieuwland M; Colin EM; Boumans D; Vermeer M; Brouwer E; Alves C
    Clin Rheumatol; 2024 Jan; 43(1):349-355. PubMed ID: 37650990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ocular complications of giant cell arteritis].
    Liozon E; Ly KH; Robert PY
    Rev Med Interne; 2013 Jul; 34(7):421-30. PubMed ID: 23523078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis.
    Font C; Cid MC; Coll-Vinent B; López-Soto A; Grau JM
    Br J Rheumatol; 1997 Feb; 36(2):251-4. PubMed ID: 9133940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
    Becker M
    Praxis (Bern 1994); 2020; 109(5):347-354. PubMed ID: 32233763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.